Henry Schein price to free cash flow HSIC

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026: 16.6×
10-year median: 18.0×
Against its 10-year history: 31st; percentile: 0 is its lowest day, 100 its highest
10-year range: 10.6× to 28.0×
Peer median: 12.8×

Henry Schein's price to free cash flow is 16.6× as of Oct 23, 2026.

That is below its ten-year median of 18.0×, lower than on 69% of days in the last ten years.

Over that time it ranged from 10.6× in May 2020 to 28.0× in Mar 2024.

The median for 3 medical distribution stocks of a similar size is 12.8×.

Price to free cash flow over time

median 18×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	16.6×	14.4×	23.4×
2025	22.2×	11.4×	22.6×
2024	19.0×	14.8×	28.0×
2023	15.2×	13.9×	24.8×
2022	20.5×	13.8×	21.4×
2021	14.9×	13.6×	21.6×
2020	20.0×	10.6×	21.6×
2019	16.9×	14.9×	18.5×
2018	17.2×	16.8×	21.8×
2017	17.5×	16.8×	20.3×
2016	16.4×	16.1×	26.3×
2015	21.0×	15.5×	21.1×
2014	17.8×	12.5×	17.8×
2013	14.5×	12.6×	19.7×
2012	12.2×	10.1×	13.4×
2011	10.5×	9.8×	14.4×

Against its peers

Companies in Medical - Distribution nearest Henry Schein's size, closest first, today.

Company	Price to free cash flow
HSICHenry Schein	16.6×
CAHCardinal Health	12.8×
CORCencora	15.6×
HLFHerbalife	4.4×
Peer median	12.8×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Henry Schein

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.